A detailed history of Massachusetts Financial Services CO transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 190,662 shares of AMRX stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
190,662
Previous 195,279 2.36%
Holding current value
$1.61 Million
Previous $1.24 Million 27.9%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$6.42 - $8.83 $29,641 - $40,768
-4,617 Reduced 2.36%
190,662 $1.59 Million
Q2 2024

Aug 09, 2024

SELL
$5.36 - $7.11 $142,190 - $188,614
-26,528 Reduced 11.96%
195,279 $1.24 Million
Q1 2024

May 14, 2024

BUY
$5.24 - $6.34 $1.16 Million - $1.41 Million
221,807 New
221,807 $1.34 Million
Q2 2022

Aug 09, 2022

SELL
$3.01 - $4.46 $240,625 - $356,541
-79,942 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$3.9 - $4.89 $3,194 - $4,004
819 Added 1.04%
79,942 $333,000
Q4 2021

Feb 10, 2022

SELL
$3.95 - $5.85 $6,327 - $9,371
-1,602 Reduced 1.98%
79,123 $379,000
Q3 2021

Nov 10, 2021

SELL
$4.31 - $5.64 $4,564 - $5,972
-1,059 Reduced 1.29%
80,725 $431,000
Q2 2021

Aug 13, 2021

BUY
$5.12 - $6.82 $3,584 - $4,774
700 Added 0.86%
81,784 $419,000
Q1 2021

May 13, 2021

SELL
$4.74 - $7.38 $45,556 - $70,929
-9,611 Reduced 10.6%
81,084 $546,000
Q4 2020

Feb 12, 2021

BUY
$3.95 - $5.42 $358,245 - $491,566
90,695 New
90,695 $414,000
Q3 2018

Oct 25, 2018

SELL
$16.4 - $24.27 $1.47 Million - $2.18 Million
-89,933 Closed
0 $0
Q2 2018

Jul 30, 2018

BUY
$13.95 - $20.2 $1.25 Million - $1.82 Million
89,933 New
89,933 $1.48 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.28B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.